ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

596 hedge funds and large institutions have $23.4B invested in Alexion Pharmaceuticals Inc in 2018 Q1 according to their latest regulatory filings, with 81 funds opening new positions, 219 increasing their positions, 225 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
596
Holders Change
+10
Holders Change %
+1.71%
% of All Funds
13.68%
Holding in Top 10
16
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.88%
% of All Funds
0.37%
New
81
Increased
219
Reduced
225
Closed
63
Calls
$468M
Puts
$434M
Net Calls
+$34.2M
Net Calls Change
+$82.4M

Top Buyers

1
Jennison Associates
Jennison Associates
New York
$835M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$2.15B
3
EVM
Eaton Vance Management
Massachusetts
$257M
4
MWNA
Marshall Wace North America
New York
$121M
5
Millennium Management
Millennium Management
New York
$104M

Top Sellers

1
State Street
State Street
Massachusetts
$1.01B
2
Goldman Sachs
Goldman Sachs
New York
$275M
3
Citadel Advisors
Citadel Advisors
Florida
$77.3M
4
Sands Capital Management
Sands Capital Management
Virginia
$384M
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
$62.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
IWP
651
Icon Wealth Partners
Texas
– -$2K -13 Closed
Financial Engines Advisors
652
Financial Engines Advisors
California
– -$1K -9 Closed
RPC
653
Rossmore Private Capital
Connecticut
– -$1.08K -9 Closed
THWM
654
Taylor Hoffman Wealth Management
Virginia
– -$1K -8 Closed
23 24 25 26
27